Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Cell Reports|December 3, 2015
H4K44 Acetylation Facilitates Chromatin Accessibility during MeiosisJialei Hu, Greg Donahue, Jean Dorsey, et al.
Frontiers in Immunology|October 6, 2023
Safety and immunogenicity of a modified Omicron-adapted inactivated vaccine in healthy adults: a randomized, double-blind, active-controlled Phase III clinical trialJialei Hu, Yueyue Liu, Shuo Liu, et al.
Vaccines|April 27, 2026
Safety and Immunogenicity of a Sabin Strain-Based Inactivated Polio Vaccine: A Phase III, Randomized, Blinded, Positive-Control Clinical Trial in Infants Aged Two MonthsHao Zhang, Yanjun Chen, Bidan Xu, et al.
ACS Synthetic Biology|May 22, 2025
Metabolic Engineering of <i>Clostridium tyrobutyricum</i> for High-Yield <i>n</i>-Butanol Production by Increasing Intracellular Reducing Equivalent with NADPH-Dependent 3-Hydroxybutyryl-CoA DehydrogenaseJun Feng, Qingke Wang, Xiaolong Guo, et al.
Vaccine|April 6, 2025
Safety, immunogenicity and immune persistence of a lyophilized purified human diploid cells rabies vaccine following rabies PEP regimen Essen and Zagreb: A randomized, blinded controlled phase 3 trial in healthy participants aged 10-60 years oldGuifan Li, Shouchun Cao, Bidan Xu, et al.
Vaccines|November 26, 2025
Immunogenicity and Safety of Sabin Strain Inactivated Poliovirus Vaccine Booster Dose Administered Separately or Concomitantly with Inactivated Hepatitis A Vaccine or Measles-Mumps-Rubella Combined Attenuated Live Vaccine: An Open-Labelled, Randomized, Controlled, Phase 4 Clinical TrialJialei Hu, Weixiao Han, Kai Chu, et al.
Human Vaccines & Immunotherapeutics|June 22, 2018
One year immunogenicity and safety of subunit plague vaccine in Chinese healthy adults: An extended open-label studyJialei Hu, Lei Jiao, Yuemei Hu, et al.
Epigenetics & Chromatin|September 16, 2020
Systematic genetic and proteomic screens during gametogenesis identify H2BK34 methylation as an evolutionary conserved meiotic markMarion Crespo, Lacey J Luense, Marie Arlotto, et al.
Chinese Medical Journal|June 7, 2022
A broadly neutralizing human monoclonal antibody against the hemagglutinin of avian influenza virus H7N9Jingxin Li, Li Zhang, Linlin Bao, et al.
Human Vaccines & Immunotherapeutics|November 28, 2022
Lot-to-lot consistency, immunogenicity, and safety of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults: A randomized, double-blind, phase IV trialDandan Zhu, Yuansheng Hu, Zhiwei Jiang, et al.
Pageof 6